Valsartan Tablet
Product Images NDC 42291-859

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 42291-859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40 (856 30 40mg)

Label for Valsartan Tablets, USP 40 mg oral tablets, containing 30 tablets per bottle. The label includes dosage strength, storage instructions, manufacturer information (AvKARE and Amneal Pharmaceuticals), and barcode. The label is for prescription use only.*

FDA Label Image

80 (857 90 80mg)

Valsartan Tablets, USP 80 mg oral tablets label by AvKARE. The label includes storage instructions, dosage note to see package insert, manufacturer information, and a barcode. It indicates a package size of 90 tablets and the product is Rx only.*

FDA Label Image

160 (858 90 160mg)

Valsartan Tablets, USP 160 mg oral tablet label showing the active ingredient strength per tablet. Label includes manufacturer AvKARE with secondary manufacturer Amneal Pharmaceuticals, and dosage/storage instructions. Package contains 90 tablets. Barcode and NDC number 42291-858-90 are visible.*

FDA Label Image

320 (859 90 320mg)

Label for Valsartan Tablets USP, 320 mg oral tablets by AvKARE. The package contains 90 tablets and is labeled for prescription use only (Rx). The label includes storage instructions, manufacturer details for AvKARE and Amneal Pharmaceuticals, and a UPC barcode.*

FDA Label Image

F9674dc4-figure-01 (Valsartan Tablets Usp 1)

Chemical structure diagram of the active ingredient valsartan, showing its molecular composition including aromatic rings, a tetrazole group, and a butyl side chain characteristic of valsartan's molecular arrangement.*

FDA Label Image

1 (Valsartan Tablets Usp 2)

A forest plot chart titled 'Effects on Mortality Amongst Subgroups in VALIANT,' displaying data points comparing mortality impact of Valsartan versus Captopril across various patient subgroups. The horizontal axis shows a scale from 0.5 (favors Valsartan) to 1.5 (favors Captopril), with subgroups including age ranges, sex, ethnicity, geographic regions, and beta-blocker use. Each subgroup has a corresponding point estimate and confidence interval line, indicating relative mortality effect.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.